It’s A New Day A very positive outlook for HLTH this morning ....and that's great news for those long on the stock.
Morningstar's Fair Value sp is $.16 after market close yesterday. Barchart is now at a 40% Buy with a strengthening short term outlook. Resistance points are currently at $.13, $.14 and $.15.
HLTH is trading at over $.12 CAD on the Frankfurt Exchange with above average volumes and the Ask at $.125 CAD. A steady, sustainable climb over the next few weeks with another NR on Healthview or ASIC Power will make HLTH a very attractive, cheap option for investors getting in on the ground floor. Those who bought in at $.10 a couple of days ago are already up 15%.
I also believe that reducing their position in Shanghai Biotechnologies Devices was a calculated and strategic move as SBD could not meet the manufacturing targets for the ViraxClear LOIs. While unfortunate it allows HLTH to focus on profitability and not on possibility.
GLTA!!!
https://www.sedar.com/GetFile.do?lang=EN&docClass=8&issuerNo=00021175&issuerType=03&projectNo=03168167&docId=4879089